通天口服液联合西医常规治疗气虚血瘀证急性脑梗死临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R743.3

基金项目:

河南省医学科技攻关计划项目(LHGJ20200979)


Clinical Study on Tongtian Oral Liquid Combined with Conventional Western Medicine in Treating Acute Cerebral Infarction with Qi Deficiency and Blood Stasis Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察通天口服液联合西医常规治疗气虚血瘀证急性脑梗死(ACI) 的临床疗效。方法:选择 2022年1月—2023年12月在许昌市中心医院治疗的104例气虚血瘀证ACI患者,根据随机数字表法分为中西医 结合组和常规组各52例。常规组采用阿司匹林肠溶片、丁苯酞软胶囊等常规治疗,中西医结合组在常规组的 基础上加服通天口服液。比较2组总有效率、神经损伤程度[美国国立卫生研究院卒中量表(NIHSS) 评分]、 中医证候评分、脑血流动力学指标[大脑中动脉(MCA) 平均血液流速(Vm)、阻力指数(RI)]、神经因子 [髓鞘碱性蛋白(MBP)、中枢神经特异蛋白(S-100β)、神经元特异性烯醇化酶(NSE)] 水平、Barthel指数 (BI) 与安全性分析。结果:治疗后,中西医结合组总有效率为88.46%(46/52),常规组为73.08%(38/52),2组 比较,差异有统计学意义(P<0.05)。治疗后,2组NIHSS评分、中医证候评分均较治疗前降低(P<0.05), 且中西医结合组2项评分均低于常规组(P<0.05)。治疗后,2组MCA-Vm水平均较治疗前上升(P<0.05), MCA-RI值均较治疗前下降(P<0.05);且中西医结合组MCA-Vm水平高于常规组,MCA-RI值低于常规组, 差异均有统计学意义(P<0.05)。治疗后,2组MBP、S-100β、NSE水平均较治疗前下降(P<0.05),且中西 医结合组3项指标水平均低于常规组(P<0.05)。治疗后,2组BI评分均较治疗前上升(P<0.05);且中西医 结合组BI评分高于常规组(P<0.05)。中西医结合组不良反应发生率为5.77% (3/52),低于常规组15.38% (8/52),但差异无统计学意义(P>0.05)。结论:常规西药联合通天口服液治疗气虚血瘀证ACI可提高临床疗 效,减轻脑神经功能损伤,改善脑血流动力学状态,提高患者日常生活能力,且安全性相对较高。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Tongtian Oral Liquid combined with conventional western medicine in the treatment of acute cerebral infarction(ACI)with qi deficiency and blood stasis syndrome.Methods: A total of 104 ACI patients with qi deficiency and blood stasis syndrome treated at Xuchang Central Hospital from January 2022 to December 2023 were divided into the integrated Chinese-western medicine group and conventional group according to the random number table method,52 cases in each group.The conventional group was treated with conventional treatment of Aspirin Enteric-Coated Tablets and Butylphthalide Soft Capsules, and the integrated Chinese-western medicine group was additionally treated with Tongtian Oral Liquid based on the conventional treatment. The total effective rate,neurological impairment [National Institute of Health Stroke Scale(NIHSS)scores],traditional Chinese medicine syndrome scores,hemodynamic parameters [mean blood flow velocity(Vm)of middle cerebral artery (MCA), resistance index(RI)], neural factors [myelin basic protein(MBP), central nervous specific protein(S- 100β),neuron-specific enolase(NSE)],Barthel Index(BI),and safety were all compared between the two groups. Results: The total effective rate was 88.46%(46/52)in the integrated Chinese-western medicine group , and was 73.08%(38/52)in the conventional group,the difference being significant(P<0.05).After treatment,both groups showed reduced NIHSS and traditional Chinese medicine syndrome scores(P<0.05), with greater reductions in the integrated Chinese -western medicine group(P<0.05). After treatment, the levels of MCA-Vm in both groups increased compared with those before treatment(P<0.05),and the levels of MCA-RI decreased compared with those before treatment(P<0.05);the level of MCA-Vm in the integrated Chinese-western medicine group was higher than that in the conventional group, and the value of MCA-RI was lower than that in the conventional group, differences being significant(P<0.05). The levels of MBP, S-100β, and NSE decreased in both groups compared with those before treatment(P<0.05),with the above levels lower in the integrated Chinese-western medicine group(P<0.05). The BI scores improved in both groups(P<0.05),with higher BI scores in the integrated Chinese-western medicine group(P<0.05).The incidence of adverse reactions in the integrated Chinese-western medicine group was 5.77%(3/ 52),lower than that of 15.38%(8/52)in the conventional group,there being no significant difference(P>0.05). Conclusion:The combination of Tongtian Oral Liquid with conventional western medicine demonstrates superior effect in treating ACI with qi deficiency and blood stasis syndrome,improving neurological function,cerebral hemodynamics, and daily living activities with higher safety.

    参考文献
    相似文献
    引证文献
引用本文

张晓阳,李涛,张会芳.通天口服液联合西医常规治疗气虚血瘀证急性脑梗死临床研究[J].新中医,2025,57(18):42-46

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-09-25
  • 出版日期:
文章二维码